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Objective: We examined the effects of photobiomodulation (PBM) on stereological parameters, and gene
expression of Runt-related transcription factor 2 (RUNX2), osteocalcin, and receptor activator of nuclear factor
kappa-B ligand (RANKL) in repairing tissue of tibial bone defect in streptozotocin (STZ)-induced type 1
diabetes mellitus (TIDM) in rats during catabolic response of fracture healing. Background data: There were
conflicting results regarding the efficacy of PBM on bone healing process in healthy and diabetic animals.
Materials and methods: Forty-eight rats have been distributed into four groups: group 1 (healthy control, no
TIDM and no PBM), group 2 (healthy test, no TIDM and PBM), group 3 (diabetic control, TIDM and no PBM),
and group 4 (diabetic test, no TIDM and PBM). TIDM was induced in the groups 3 and 4. A partial bone defect
in tibia was made in all groups. The bone defects of groups second and fourth were irradiated by a laser
(890 nm, 80Hz, 1.5 J/cm2). Thirty days after the surgery, all bone defects were extracted and were submitted to
stereological examination and real-time polymerase chain reaction (RT-PCR). Results: PBM significantly
increased volumes of total callus, total bone, bone marrow, trabecular bone, and cortical bone, and the numbers
of osteocytes and osteoblasts of callus in TIDM rats compared to those of callus in diabetic control. In addition,
TIDM increased RUNX2, and osteocalcin in callus of tibial bone defect compared to healthy group. PBM
significantly decreased osteocalcin gene expression in TIDM rats. Conclusions: PBM significantly increased
many stereological parameters of bone repair in an STZ-induced TIDM during catabolic response of fracture
healing. Further RT-PCR test demonstrated that bone repair was modulated in diabetic rats during catabolic
response of fracture healing by significant increase in mRNA expression of RUNX2, and osteocalcin compared
to healthy control rats. PBM also decreased osteocalcin mRNA expression in TIDM rats.
Keywords: photobiomodulation, low-level laser therapy, diabetes mellitus, osteotomy, stereology, real-time
polymerase chain reaction, rat
Introduction
Globally, an estimated 422 million adults had dia-betes mellitus (DM) in 2014.1 Type 1 diabetes mellitus
(TIDM) increases the risk of fracture. DM induces hypergly-
cemia and increased advanced glycation end-product forma-
tion, reactive oxygen species generation, inflammation,2 and
absence of the anabolic effects of insulin and amylin,3 and
impaired bone’s responses to mechanical loading.4 These
factors lead to increased number of osteoclasts and reduced
numbers of osteoblasts and bone formation.2 Further, TIDM
causes thinning of the bone cortex, and decline in bone for-
mation and mineralization rate. As a result, the quality of bone
declines, which leads to a greater risk of fracture.5
Several animal studies have suggested that photo-
biomodulation (PBM) attenuates inflammation, stimulates vi-
ability and cell proliferation of healthy bone marrow
mesenchymal stem cells (BMMSCs) in vivo6 and promotes
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fracture healing, and increases new bone formation.7,8 PBM
could reduce pain and accelerate the fracture process in pa-
tients.9 In another human investigation, Nesioonpour et al. re-
ported that PBM (low-level laser therapy) could decrease pain
after surgery, and PBMwas easily tolerated by patients.10 Some
studies have demonstrated that PBM promotes bone formation
in diabetic animals. Patrocinio-Silva et al. utilized PBM
(808nm laser, 100mW, 120 J/cm2) on non-fractured long bones
in streptozotocin (STZ)-induced TIDM rats. They started PBM
just one week after STZ injection. PBM caused increase in the
cortical area and Runt-related transcription factor 2 (RUNX2)
expression.11 Nascimento et al. reported that PBM [780 infra-
red gallium-aluminum-arsenide (IR GaAlAs) laser, 70mW,
17.5 J/cm2] significantly improved bone healing in TIDM in
animals.12 Akyol and Gu¨ngo¨rmu¨sx found that PBM (GaAlAs
laser, 808nm, 2· 5 J/cm2) stimulates trabecular bone formation
of bone defect in femurs in STZ-induced TIDM rats.13
However, other studies show that there are inconsistent
results about positive effects of PBM on fracture healing in
normal and diabetic animals.14–19
The process of fracture healing could be separated into
two sets of anabolic (bone forming) and catabolic (bone
remodeling) responses. Controlling catabolism can be as
important as anabolic stimulation.20
To the best of our knowledge, none of the published studies
has investigated the effects of PBM with pulse wave laser on
stereological parameters, and gene expression of RUNX2, os-
teocalcin, and receptor activator of nuclear factor kappa-B li-
gand (RANKL) in repairing tissue of tibial partial bone defect
(partial osteotomy) in the STZ-induced TIDM in rats during
catabolic response. In this study, we examined the effects of
PBM on stereological parameters, and gene expression of
RUNX2, osteocalcin and RANKL in repairing tissue of tibial
partial osteotomy in the STZ-induced TIDM in rats during
catabolic response of fracture healing. The results of this study
could improve fracture healing in diabetic patients.
Materials and Methods
Animals and study design
Forty-eight 4-month-old female Wistar rats have been
randomly divided into four groups of 12 each: group one
(healthy control, no TIDM and no PBM), group two (heal-
thy test, no TIDM and PBM), group three (diabetic control,
TIDM and no PBM), and group four (diabetic test, no TIDM
and PBM). TIDM was induced in the third and fourth
groups. We made a partial bone defect in the right tibia of
all the groups. The bone defects of second and fourth groups
were irradiated by a low-level laser. Thirty days after the
surgery, all rats were euthanized and all bone defects were
extracted. Six bone defects of each group were submitted to
histological and stereological examination, and remaining
six underwent real-time polymerase chain reaction (RT-
PCR). All techniques of current investigation were con-
firmed by the human and animal Ethics commission at
Shahid Beheshti University of Medical Sciences.
Induction of TIDM
We induced TI DM in the third and fourth groups by
dissolved STZ in distilled water (40mg/kg, single dose, and
intraperitoneal).21 TIDM has been defined as blood glucose
level greater than 250mg/dL, which was measured in the
blood samples made 7 days after STZ injection. The blood
glucose levels and body weights were recorded throughout
the experiment. We maintained entire animals for 1 month
after administration of STZ to establish DM.14
Surgery
The technique has been explained thoroughly in the previous
article.14 Under general anesthesia and sterile conditions, the
skin of right leg of each rat was cut longitudinally, right below
the knee joint on themedial side.Medial surface of tibia’s shaft
was exposed. A circular partial transversal standardized os-
teotomy with 1.5-mm diameter, deep to the central medullary
canal, was made in the midpoint of the bone with a low speed
drill (Delab Co., Dental Fabrik, Erfurt, Germany). Our previ-
ous study confirmed that a 1.5mm bone defect fitted well with
the dimensions of rats’ tibia bone. It means the bone tolerated
well the defect, and there was no complete fracture after partial
osteotomy in the site of defect in tibia in diabetic animals.14
The site was irrigated with saline solution to avoid
burning. The muscles were sutured with a 03 catgut, and the
skin was sutured with a 04 nylon reverse cutting needle. The
rats received antibiotic therapy injections with ceftriaxone
(50mg/kg, intramuscular) immediately before the surgery
and 24 and 48 h after the surgery.14
Photobiomodulation
A laser unit (Mustang 2000; Technical Co., LO7 pen,
Moscow, Russia) has been used. The specifications of laser
are shown in Table 1. The laser protocol for this study was
applied successfully on a complete osteotomy in an exper-
imental rat model.7 PBM was started on day 1 and was
followed on the right tibia thrice per week for 30 days. In the
test-irradiated rats, the total bone, including bone defect,
was completely irradiated by three laser shots (Fig. 1).
Thirty days after the beginning of treatments, all the rats
have been euthanized. We extracted the right tibias of six
rats for the histological examinations and the series of six
samples have been frozen at -80C for RT-PCR tests.
Stereological study
Measurement of bone volumes. All techniques were ex-
plained completely in our previous studies.7,22 Live pictures of
the callus in bone defect were evaluated using a projecting
microscope. All volumes (V), including total volume of callus
(mm3), bone marrow volume (mm3), trabecular bone volume
(mm3), and cortical bone volume (mm3), were calculated
using the Cavalieri method:
Table 1. Specifications of the Laser Used
Parameters Dose and unit
Peak power output 80W
Power density 1.15W/cm2
Wave length 890 nm
Pulse frequency 80Hz
Spot size 1 cm2
Pulsed duration 180 nsec
Duration of exposure for each point 1300 sec
Energy density 1.5 J/cm2
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V¼Sp· a=p · t
where Sp is the total of points hitting a callus section, a/p is
the area associated with each point, and t is distance be-
tween the sampled sections.7,22
Estimation of number of bone cells. The dissector
method was used to estimate numerical density and total
number of bone cells.7,22 Numerical density of cells was
obtained by
Nv¼SQ =(h · a=f ·Sp · t=BAð Þ
where SQ- is the number of cells, including osteocytes,
osteoblasts, and osteoclasts counted (103) in all the dissec-
tors, h is the height of the optical dissector, a/f is the area of
the counting frame, Sp is the total number of counted
frames, BA is the microtome block advance to cut the block
(25 lm), and t is the mean of the final section thickness
(20 lm). The following formula was used to estimate the
total number of bone cells: N (bone cell) =Nv·V (final).7,22
RNA extraction and RT-PCR
RNA extraction and RT-PCR techniques were described
completely in our previous study.22 The total RNA was
extracted using Trizol reagents (Invitrogen, Carlsbad, CA)
using a tissue lyser instrument (Qiagen, GmbH, Germany).
cDNA synthesis was performed using the Revert Aid First
Strand cDNA synthesis kit (Fermentas, Vilnius, Lithuania).
Gene expression of RUNX2, osteocalcin, and RANKL was
monitored by quantitative RT-PCR using the SYBR Green
PCR Master Mix (Takara Bio, Kusatsu, Shiga, Japan). The
expression values were normalized by the genometric mean
of 18s rRNA. The primers used to amplify cDNA are shown
in Table 2. For each sample, three replicates were produced
for each target gene.22
Statistical analysis
We reported all data as mean – standard deviation. One-
way analysis of variance (ANOVA) and the least significant
difference (LSD) were used to compare changes among
groups of stereological and gene expression data (with
normal distribution). A p-value of <0.05 was considered
statistically significant.
Results
General observations
TIDM animals of group 4 showed decline in body weight
at the final measurement (Table 3).
Stereological examination
Light micrographs of histological parameters are shown
in Fig. 2. Findings of stereological examinations are pre-
sented in Figs. 3–9.
In terms of total volumes (mm3) of callus, bone marrow,
and cortical bone, findings of the statistical analysis revealed
a significant reduction in control diabetic compared to other
groups (LSD test, All p = 0.000). We found a significant
reduction in total volume of callus of diabetic test compared
to healthy control (LSD test, p= 0.024). The statistical dif-
ference in total volume of callus between healthy test and
diabetic test was close to significant difference (LSD test,
p = 0.059). Increased value of cortical bone volume in
healthy test was close to significant difference compared to
diabetic test (LSD test, p= 0.054).
LSD test revealed a significant decrease in trabecular
bone volume (mm3) of diabetic control group compared to
healthy control, healthy test, and diabetic test groups
( p = 0.000, p= 0.000, and p = 0.001 respectively). Also,
there was a significant difference in trabecular bone volume
(mm3) of diabetic test group and other test groups (LSD test,
all p = 0.001) (Figs. 3–9).
LSD test demonstrated significant decreases in osteocyte
number (106) of diabetic control rats compared to healthy
rats, healthy test, and diabetic test rats ( p = 0.000, p = 0.000,
and p = 0.001 respectively). LSD test detected significant
decreases in osteocyte numbers of diabetic test rats com-
pared to healthy control and healthy test rats ( p = 0.005,
p = 0.009), and significant increase compared to diabetic
control ( p = 0.001) (Fig. 7).
We observed significant reduction of osteoblast number
(106) of diabetic control rats compared to healthy control,
healthy test, and diabetic test rats (LSD test, p = 0.000,
p = 0.000, and p = 0.002 respectively). Based on the LSD
test, significant decreases were found in osteoblast number
of diabetic test group compared to healthy control and
healthy test groups ( p= 0.010, p = 0.025), and significant
increase compared to diabetic control ( p = 0.002) (Fig. 8).
FIG. 1. Laser radiation technique.
Table 2. Primers of the Studied Genes
for Real-Time Polymerase Chain Reaction
Gene Primer sequences
RUNX2 Forward: GTGCCTCCAACCTGTGTTTTCCC
Reverse: GTTTCGGTTTGCTACTGGGTGGG
Osteocalcin Forward: GCTTCAGCTTTGGCTACTCTCC
Reverse: GCTGTGCCGTCCATACTTTC
RANKL Forward: CAGCATCAAAATCCCAAGTTCGC
Reverse: TTTGAAAGCCCCAAAGTACGTCGC
RUNX2, Runt-related transcription factor 2; RANKL, receptor
activator of nuclear factor kappa-B ligand.
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We found a significant reduction in osteoclast number
(103) of diabetic control rats compared to other groups (LSD
test, all p = 0.000) (Fig. 9).
RT-PCR test
Based on the LSD test results, there was a significant
increase in RUNX2 of diabetic control compared to healthy
control and healthy test groups ( p = 0.020 and p = 0.049,
respectively). Our observation showed a significant increase
in Osteocalcin of diabetic control group compared to those
in healthy test, diabetic test, and healthy control groups
( p = 0.002, p = 0.005, and p = 0.033 respectively). There
were significant increases in RANKL of diabetic control
group in comparison with the healthy test group ( p = 0.041).
Discussion
We investigated the effects of PBM on stereological pa-
rameters, and gene expression using RT-PCR of RUNX2,
osteocalcin, and RANKL levels in callus of tibial bone defect
in the TIDM rats during catabolic response of fracture
healing. TIDM has decreased entire stereological parameters
of callus compared to those of healthy group. PBM (890 nm,
80Hz, 1.5 J/cm2) increased the number of osteocytes and
osteoblasts within the callus in TIDM rats compared to those
in diabetic control. PBM has not increased bony cells
number of the healthy rats.
Compared to healthy control group, fracture healing was
delayed in diabetic rats during the catabolic response of
fracture healing. Our findings are consistent with the find-
ings of earlier studies, which reported that osteoblast num-
ber, new mineralized tissue area, blood vessel count,23 and
sum of histologic scores24 of fracture healing in bone de-
fects at the catabolic response were lesser in TIDM rats than
those of control healthy animals.
The energy density of laser used in this work has been
selected according to the previous reports of this laboratory,
in which it was indicated that the 890-nm laser at 1.5 J/cm2
and 80Hz frequency was able to increase bone strength in
complete osteotomy7 and partial osteotomy14 bone defects.
The below hypothesis, which tries to describe the absence
of biostimulatory effect of the PBM on stereological pa-
rameters of partial osteotomy in healthy rats during cata-
bolic response, can be suggested as follows:
Clinical and paraclinical information, such as bone min-
eral density, histological and biochemical parameters, and
gene expression findings can assist clinicians in determining
the best treatment for patients with bone diseases.24 Fun-
damental function of bone is to resist mechanical injury and
absorb pressure. Bone strength depends on both quantity and
Table 3. Mean– Standard Deviation of Starting and Final Diabetic Blood Sugars (mg/dL)
and Mean – Standard Deviation of Starting and Final Body Weights (g) of Study Groups
Groups
Parameters Healthy control Healthy test Diabetes control Diabetes test
Starting diabetic blood glucose (mg/dL) — — 398– 110 445 – 126
Final diabetic blood glucose (mg/dL) — — 411– 163 457 – 166
Starting body weight (g) 227 – 15 235 – 23 188– 43 199 – 25
Final body weight (g) 226 – 14 231 – 24 190– 39 188 – 13
FIG. 2. Light micrographs
of studied groups (hematoxy-
lin and eosin stainingmethod).
(A) Healthy control, no TIDM
and no PBM; (B) healthy test,
no TIDM, PBM; (C) diabetic
test, TIDM and PBM; (D) di-
abetic control, TIDM, no
PBM. PBM, photobiomodula-
tion; TIDM, type 1 diabetes
mellitus; T, trabecula; F, fi-
brosis tissue; C, cartilage.
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quality of bone tissue. Quantity of bone is outlined by the
geometry and shape of the bone and the microarchitecture of
the trabecular and cortical bone morphology. Quality of
bone is characterized by intrinsic properties of bony tissue
such as turnover, mineral, and collagen. One of the major
complications of diseases that can affect the bone diseases
such as DM and osteoporosis, that is, fracture, is due to
decrease in bone strength. Consequently, any management
of bone diseases relies on improving bone power.25–31
Our results showed that PBM significantly increased the
volume of total callus, total bone, bone marrow, trabecular
bone, and cortical bone, and the number of osteocytes and
osteoblasts of callus in TIDM rats compared to those of
callus in diabetic control rats. These results (significant
differences between test-irradiated group and control group
in stereological parameters) may be in agreement with in-
crease in trabecular bone on days 20 and 30 in bone defects
of the diabetic rats in the test- irradiated group, as recently
reported by Nascimento et al.,12 and Akyol and Gu¨ngo¨r-
mu¨sx.13 Nascimento et al.12 studied the effect of PBM (780
IR GaAlAs laser, 70mW, 17.5 J/cm2) on fracture healing in
TIDM animals on days 7, 18, and 30 after osteotomy. They
found wide and thick trabecular bone formation in test and
healthy normal groups. However, in diabetic control, the
trabecular bone was thinner and more irregular on day 30.
Nascimento et al.12 also found that the new bone zone was
significantly lower in diabetic group compared to ones in
test-irradiated diabetic and healthy groups on day 30 after
surgery. Akyol and Gu¨ngo¨rmu¨sx13 studied the effects of PBM
(GaAlAs laser, 808 nm, 2 · 5 J/cm2, five sessions) on repair
FIG. 3. Mean – SD of the total volume
of callus (mm3) of the studied groups
compared by ANOVA, and LSD tests,
*p < 0.05, ***p < 0.001. SD, standard
deviation; ANOVA, analysis of variance;
LSD, least significant difference; C.H.,
control healthy; C.D., control diabetes;
T.H., test healthy; T.D., test diabetes.
FIG. 4. Mean – SD of the bone marrow
volume (mm3) of the studied groups
compared by ANOVA, and LSD tests,
***p < 0.001.
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of femoral partial osteotomy in STZ-induced TIDM in rats
on days 10 and 20 after surgery. They found a significant
increase in substantia spongiosa (cancellous bone) forma-
tion in diabetic test group compared to diabetic control
group on day 20. Akyol and Gu¨ngo¨rmu¨sx13 concluded that
PBM revealed a positive result on cancellous bone in TIDM
femoral partial osteotomy.13
Besides, we observed that TIDM has increased RUNX-2
and osteocalcin in callus of tibial bone defect compared to
healthy group, and RANKL gene expression compared to
test-irradiated healthy rats. PBM significantly decreased
osteocalcin gene expression in TIDM rats.
Recently, Park and Kang32 evaluated the effect of PBM
(980-nm GaAlAs diode laser, 0.01 W, 60 sec, and 13.95 J/cm2,
every day) on the healing of extracted dental sockets in
STZ-induced TIDM and normal rats on days 3, 5, 7, and
14 days after surgery. The samples were tested by hema-
toxylin and eosin method and reverse transcription-PCR.
Compared to other groups, bone formation was inferior in
diabetic rats on day 14. Bone formation in test-irradiated
rats was more prominent than diabetic control. The density
of RUNX-2 expression was considerably higher in test-
irradiated diabetic rats than in diabetic control at 5, 7, and
14 days. Osteocalcin mRNA expression rate increased in all
study groups, except for diabetic control. Osteocalcin
mRNA expression rate was also higher in the test group than
in nonirradiated diabetic rats on day 3. Similar expression
of collagen type I mRNA was found in diabetic control and
test-irradiated diabetic rats on days 3 and 14.32 Magri et al.33
studied the effects of PBM (808 nm, 100mW, and 30, 60,
FIG. 5. Mean – SD of the cortical
bone volume (mm3) of the studied
groups compared by ANOVA, and LSD
tests, ***p < 0.001. Increased value of
cortical bone volume in healthy test was
close to significant difference compared
to diabetic test (LSD test, p = 0.054).
FIG. 6. Mean – SD of the trabecular
bone volume (mm3) of the studied
groups compared by ANOVA, and LSD
tests, **p< 0.01, ***p < 0.001.
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and 120 J/cm2, thrice per week) on healing of tibial bone
defect of STZ-induced TIDM in rats on days 15 and 30 after
surgery. PBM started 15 days after STZ injection.33 They
observed a marked increase of RUNX2 on day 15 in test
group compared to diabetic control. RUNX2 immunoexpres-
sion was the same among the study groups on day 30. Similar
results forRANKLwere reported byMagri et al.33 for all study
groups on day 15. More immunoexpression of RANKL was
reported with energy densities of 30 and 120 J/cm2 compared
to diabetic control on day 30.33 Interestingly, Magri et al.33
reported no statistically marked difference for the biome-
chanical test of studied groups on days 15 and 30.
Our RT-PCR test established that fracture repair was
modulated in TIDM rats during catabolic response by sig-
nificant enhances in RUNX2 and osteocalcin expressions
compared to healthy control rats. Also, PBM decreased
osteocalcin mRNA expression in diabetic rats during cata-
bolic response of fracture healing. As bone calcification
begins, osteocalcin is released by osteoblasts and increases
only in the later stages of osteoblast differentiation.34 Ad-
ditional studies should be performed to offer more evidence
regarding the stimulatory effects of PBM on bone repair in
TIDM bone defect.
Conclusions
PBM was capable of biostimulating bone repair in STZ-
induced TIDM during catabolic response of fracture healing,
FIG. 7. Mean – SD of the osteocyte
number (106) of the studied groups
compared by ANOVA, and LSD tests
**p < 0.01, ***p < 0.001.
FIG. 8. Mean – SD of the osteoblast
number (106) of the studied groups
compared by ANOVA, and LSD tests
*p < 0.05, **p< 0.01, ***p < 0.001.
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by significant increase of volumes of total callus, total bone,
bone marrow, trabecular bone, and cortical bone, and the
number of osteocytes and osteoblasts compared to control
rats. Further, RT-PCR test established that bone repair was
modulated in diabetic rats during catabolic response of frac-
ture healing by significant increase in RUNX-2 and osteo-
calcin expressions compared to healthy control rats. PBM
also decreased osteocalcin mRNA expression in diabetic rats.
Acknowledgments
We extend our appreciation for financial support (grant no.
11608) to the cellular and molecular biology research center,
and the Vice Chancellor of Research at Shahid Beheshti
University of Medical Sciences, Tehran, Iran.
Author Disclosure Statement
No competing financial interests exist.
References
1. http://apps.who.int/iris/bitstream/10665/204871/1/9789241
565257_eng.pdf
2. Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone
and fracture healing. Curr Osteoporos Rep 2015;13:327–335.
3. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteo-
porosis in patients with diabetes mellitus. J Bone Miner Res
2007;22:1317–1328.
4. Parajuli A, Liu C, Li W, et al. Bone’s responses to me-
chanical loading are impaired in type 1 diabetes. Bone
2015;81:152–160.
5. Blakytny R, Spraul M, Jude EB. Review: the diabetic bone:
a cellular and molecular perspective. Int J Low Extrem
Wounds 2011;10:16–32.
6. Mostafavinia A, Dehdehi L, Ghoreishi SK, Hajihossainlou
B, Bayat M. Effect of in vivo low-level laser therapy on bone
marrow-derived mesenchymal stem cells in ovariectomy-
induced osteoporosis of rats. J Photochem Photobiol B 2017;
175:29–36.
7. Mostafavinia A, Farahani RM, Abbasian M, et al. Effect of
pulsed wave low-level laser therapy on tibial complete
osteotomy model of fracture healing with an intramedullary
fixation. Iran Red Crescent Med J 2015;17:e32076.
8. Sella VR, do Bomfim FR, Machado PC, da Silva Morsoleto
MJ, Chohfi M, Plapler H. Effect of low-level laser therapy
on bone repair: a randomized controlled experimental
study. Lasers Med Sci 2015;30:1061–1068.
9. ChangWD,Wu JH,WangHJ, Jiang JA. Therapeutic outcomes
of low-level laser therapy for closed bone fracture in the human
wrist and hand. Photomed Laser Surg 2014;32:212–218.
10. Nesioonpour S, Mokmeli S, Vojdani S, et al. The effect of
low-level laser on postoperative pain after tibial fracture
surgery: a double-blind controlled randomized clinical trial.
Anesth Pain Med 2014;4:e17350.
11. Patrocinio-Silva TL, de Souza AM, Goulart RL, et al. The
effects of low-level laser irradiation on bone tissue in dia-
betic rats. Lasers Med Sci 2014;29:1357–1364.
12. Nascimento MF, Almeida BM, Cunha JL, et al. Improve-
ment of bone repair in diabetic rats subjected to 780 nm
low-level laser therapy. Acta Cir Bras 2015;30:660–667.
13. Akyol UK, Gu¨ngo¨rmu¨sx M. Effect of biostimulation on
healing of bone defects in diabetic rats. Photomed Laser
Surg 2010;28:411–416.
14. Mostafavinia A, Razavi S, Abdollahifar M, et al. Evalua-
tion of the effects of photobiomodulation on bone healing
in healthy and streptozotocin-induced diabetes in rats.
Photomed Laser Surg 2017;35:537–545.
15. Kazem Shakouri S, Soleimanpour J, Salekzamani Y, Os-
kuie MR. Effect of low-level laser therapy on the fracture
healing process. Lasers Med Sci 2010;25:73–77.
16. Mota FC, Belo MA, Beletti ME, Okubo R, Prado EJ,
Casale RV. Low-power laser therapy for repairing acute
and chronic-phase bone lesions. Res Vet Sci 2013;94:
105–110.
17. Abdi S, Bayat M, Javadieh F, Mohsenifar Z, Rezaie F, Bayat
M. The effects of helium-neon light therapy on healing of
partial osteotomy of the tibia in streptozotocin induced dia-
betic rats. Photomed Laser Surg 2009;27:907–912.
FIG. 9. Mean–SD of the osteoclast
number (103) of the studied groups com-
pared by ANOVA, and LSD tests,
***p< 0.001.
PHOTOBIOMODULATION ON OSTEOTOMY IN DIABETIC RATS 413
D
ow
nl
oa
de
d 
by
 7
8.
39
.3
5.
68
 fr
om
 w
w
w
.li
eb
er
tp
ub
.co
m
 at
 0
8/
26
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
18. Javadieh F, Bayat M, Abdi S, Mohsenifar Z, Razi S. The
effects of infrared low-level laser therapy on healing of
partial osteotomy of tibia in streptozotocin-induced diabetic
rats. Photomed Laser Surg 2009;27:641–646.
19. Magri AM, Fernandes KR, Assis L, et al. Photobiomodula-
tion and bone healing in diabetic rats: evaluation of bone
response using a tibial defect experimental model. Lasers
Med Sci 2015;30:1949–1957.
20. Little DG, Ramachandran M, Schindeler A. The anabolic
and catabolic responses in bone repair. J Bone Joint Surg Br
2007;89:425–433.
21. Mostafavinia A, Amini A, Ghorishi SK, Pouriran R, Bayat
M. The effects of dosage and the routes of administrations
of streptozotocin and alloxan on induction rate of type1
diabetes mellitus and mortality rate in rats. Lab Anim Res
2016;32:160–165.
22. Fredoni M, Ghatrehsamani M, Abdollahifar MA, Bayat S,
Bayat M. Evaluation of the effects of photobiomodulation
on vertebras in two rat models of experimental osteoporo-
sis. Lasers Med Sci 2017;32:1545–1560.
23. Yildirimturk S, Batu S, Alatli C, Olgac V, Firat D, Sirin Y.
The effects of supplemental melatonin administration on
the healing of bone defects in streptozotocin-induced dia-
betic rats. J Appl Oral Sci 2016;24:239–249.
24. Kanis J, McCloskey E, Johansson H, Cooper C, Rizzoli R,
Reginster J-Y. European guidance for the diagnosis and
management of osteoporosis in postmenopausal women.
Osteoporos Int 2013;24:23–57.
25. Lane NE, Thompson JM, Haupt D, Kimmel DB, Modin G,
Kinney JH. Acute changes in trabecular bone connectivity
and osteoclast activity in the ovariectomized rat in vivo. J
Bone Miner Res 1998;13:229–236.
26. Green D, Wallace H. Late Effects of Childhood Cancer.
London, England: CRC Press, 2003.
27. Ammann P. Determining factors of bone mechanical re-
sistance. Therapie 2002;58:403–407.
28. Martin RB. Determinants of the mechanical properties of
bones. J Biomech 1991;24:79–88.
29. Lee AJ, Ling RS, Gheduzzi S, Simon JP, Renfro RJ. Factors
affecting the mechanical and viscoelastic properties of ac-
rylic bone cement. J Mater Sci Mater Med 2002;13:723–733.
30. Tommasini SM, Nasser P, Schaffler MB, Jepsen KJ. Re-
lationship between bone morphology and bone quality in
male tibias: implications for stress fracture risk. J Bone
Miner Res 2005;20:1372–1380.
31. Nyman JS, Granke M, Singleton RC, Pharr GM. Tissue-
level mechanical properties of bone contributing to fracture
risk. Curr Osteoporos Rep 2016;14:138–150.
32. Park JJ, Kang KL. Effect of 980-nm GaAlAs diode laser ir-
radiation on healing of extraction sockets in streptozotocin-
induced diabetic rats: a pilot study. Lasers Med Sci 2012;27:
223–230.
33. Magri AM, Fernandes KR, Assis L, et al. Photo-
biomodulation and bone healing in diabetic rats: evaluation
of bone response using a tibial defect experimental model.
Lasers Med Sci 2015;30:1949–1957.
34. Tanaka S, Matsuzaka K, Sato D, Inoue T. Characteristics of
newly formed bone during guided bone regeneration:
analysis of Cbfa-1, osteocalcin, and VEGF expression. J
Oral Implantol 2007;33:321–326.
Address correspondence to:
Mohammad Bayat, PhD
Cellular and Molecular
Biology Research Center
Shahid Beheshti University of Medical Sciences
Tehran 1985717476, Iran
E-mail: mohbayat@sbmu.ac.ir
bayatenator@gmail.com
Received: January 9, 2018.
Accepted after revision: March 4, 2018.
Published online: May 23, 2018.
414 MOSTAFAVINIA ET AL.
D
ow
nl
oa
de
d 
by
 7
8.
39
.3
5.
68
 fr
om
 w
w
w
.li
eb
er
tp
ub
.co
m
 at
 0
8/
26
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
